CSIMarket
 
Syros Pharmaceuticals Inc   (SYRS)
 

News about Syros Pharmaceuticals Inc




Syros Pharmaceuticals Reports Strong First Quarter 2024 Financial Results and Advances Tamibarotene for Frontline Treatment of Hematologic Malignancies
May 14 2024
Syros Pharmaceuticals, a leading biopharmaceutical company dedicated to improving treatment options for hematologic malignancies, recently released it...

Breakthrough or Bustn Syros Pharmaceuticals Nears Milestone in HR-MDS Treatment Trial
Mar 25 2024
In a significant development for the biopharmaceutical industry, Syros Pharmaceuticals has announced the successful completion of patient enrollment i...

Syros Pharmaceuticals Sets High 2024 Milestones for Tamibarotene Amid Financial Hurdles
Jan 08 2024
Syros Pharmaceuticals, a prominent biopharmaceutical company headquartered in Cambridge, Massachusetts, has recently released its anticipated mileston...

Syros Pharmaceuticals Announces Pricing of $45 Million Underwritten Offering, Shares Surge 17.51% YTD
Dec 19 2023
Syros Pharmaceuticals, a leading biopharmaceutical company dedicated to revolutionizing the treatment of hematologic malignancies, recently ...

Tamibarotene Shows Promising Results in Phase 2 Clinical Trial for Acute Myeloid Leukemia, Boosting Syros Pharmaceuticals Amid Revenue Decline
Dec 06 2023
Syros Pharmaceuticals, a leading biopharmaceutical company focused on revolutionizing treatment options for hematologic malignancies, has recentl...

Hematologic Malignancy Revolution: Syros Pharmaceuticals Inc Faces Unique Challenges and Opportunities Amidst -3.315% Revenue Slide
Nov 16 2023
Syros Pharmaceuticals Inc, a biopharmaceutical company focused on revolutionizing hematologic malignancy treatments, recently released its f...

Syros Pharmaceuticals Releases Q3 2023 Financial Results and Charts Path for Future Growth
Nov 14 2023
Syros Pharmaceuticals, a leading biopharmaceutical company dedicated to revolutionizing the treatment of hematologic malignancies, recently ...

Extremely demanding reporting season for SYRS amid the financial time-frame ending June 30 2023
Aug 09 2023
Syros Pharmaceuticals Inc, a major player in the pharmaceutical preparations industry, has recently disclosed its financial results for the ...

Syros Pharmaceuticals Inc Faces Steep Decline in First Quarter of 2023, Resulting in Crumbling Revenue
May 12 2023
Syros Pharmaceuticals Inc has been experiencing a concerning trend of losses and negative returns on equity over the past 12 months. During this perio...

SYRS in the financial fourth quarter of 2022
Mar 03 2023
...

The Top-line took a nose-dive at amid the most recent fiscal period
Mar 03 2023
...









Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com